Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Modafinil, a wake-promoting drug initially used to treat narcolepsy, increases extracellular dopamine — an effect that increases the drug’s potential for abuse —…
Paul H. Ratner, MD, MBA, Allergist, discusses the genesis of a new treatment for allergy to airborne pollens, developed by Ashok Wahi, BS, MS, PE. Marketed as Chloraseptic…
NEW YORK (Reuters Health) – As a treatment for chronic hepatitis B, telbivudine produces a better therapeutic response than does lamivudine in both HBeAg-positive and –negative patients, according…
NEW YORK (Reuters Health) – As a treatment strategy for early Parkinson disease, initial therapy with levodopa versus pramipexole appears to make little difference in terms of eventual…
NEW YORK (Reuters Health) – For first-line tocolytic therapy before 32 weeks’ gestation, prostaglandin inhibitors appear to be the most effective and tolerable agents for delaying delivery for…
NEW YORK (Reuters Health) – Reducing blood pressure with the drug combination perindopril-indapamide reduces renal events in patients with type 2 diabetes, even when the initial blood pressure…
NEW YORK (Reuters Health) – After finding that the 5-HT3 receptor in the brain affects susceptibility to opioid dependence, scientists in California have demonstrated the efficacy of ondansetron,…
NEW YORK (Reuters Health) – The results of a small trial suggest that vitamin B12 is a safe, effective, and inexpensive treatment for recurrent aphthous stomatitis (RAS). “The…
NEW YORK (Reuters Health) – The risk of visual field loss with the antiepileptic drug vigabatrin is lower when it is given during infancy rather than later in…
NEW YORK (Reuters Health) – An ultrasensitive assessment of HIV-RNA levels in HAART-treated patients with subclinical viral loads reveals that nevirapine-based regimens are more effective in this setting…
